CVS Health Ventures
Corporate venture
- Stages
- Series A, Series B, Growth
- Cheque size
- $5M to $50M
- Based in
- United States
- Focus
- Primary & Virtual Care, Metabolic Health, Mental & Behavioural Health
CVS Health Ventures is the corporate venture arm of CVS Health, launched in 2021 and based in Woonsocket, Rhode Island. It invests in early stage companies making care more accessible and affordable, drawing on the pharmacy, insurance and care delivery businesses of its parent.
Invests where retail, pharmacy and payer channels can scale a product.
Notable investments
- Carbon Health
- Array Behavioral Care
- Vera Whole Health
The journey
How CVS Health Ventures got here, step by step.
2021
CVS Health Ventures launches
CVS Health announced the fund with an initial commitment of one hundred million dollars.
2021
Focus set on digital health
The fund targeted early stage companies improving accessibility, affordability and simplicity in consumer health.
2022
First investments announced
The team began deploying capital into digital health startups aligned with the CVS retail and insurance business.
2023
Portfolio broadens
Investments expanded across care delivery, health equity and consumer engagement tools.
2024 to 2025
Continued corporate venture activity
The fund kept making early stage investments while opening its national retail footprint to portfolio companies.
Investors at similar stages
- 7wireVentures
Venture fund
- Andreessen Horowitz Bio + Health
Venture fund
- Bessemer Venture Partners
Venture fund
- Define Ventures
Venture fund
- Elad Gil
Angel investor
- EQT Life Sciences
Venture fund